PMID- 30882021 OWN - NLM STAT- MEDLINE DCOM- 20200924 LR - 20200924 IS - 2332-7812 (Print) IS - 2332-7812 (Electronic) IS - 2332-7812 (Linking) VI - 6 IP - 3 DP - 2019 May TI - MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. PG - e547 LID - 10.1212/NXI.0000000000000547 [doi] LID - e547 AB - OBJECTIVE: To isolate and characterize muscle-specific kinase (MuSK) monoclonal antibodies from patients with MuSK myasthenia gravis (MG) on a genetic and functional level. METHODS: We generated recombinant MuSK antibodies from patient-derived clonal MuSK-specific B cells and produced monovalent Fab fragments from them. Both the antibodies and Fab fragments were tested for their effects on neural agrin-induced MuSK phosphorylation and acetylcholine receptor (AChR) clustering in myotube cultures. RESULTS: The isolated MuSK monoclonal antibody sequences included IgG1, IgG3, and IgG4 that had undergone high levels of affinity maturation, consistent with antigenic selection. We confirmed their specificity for the MuSK Ig-like 1 domain and binding to neuromuscular junctions. Monovalent MuSK Fab, mimicking functionally monovalent MuSK MG patient Fab-arm exchanged serum IgG4, abolished agrin-induced MuSK phosphorylation and AChR clustering. Surprisingly, bivalent monospecific MuSK antibodies instead activated MuSK phosphorylation and partially induced AChR clustering, independent of agrin. CONCLUSIONS: Patient-derived MuSK antibodies can act either as MuSK agonist or MuSK antagonist, depending on the number of MuSK binding sites. Functional monovalency, induced by Fab-arm exchange in patient serum, makes MuSK IgG4 antibodies pathogenic. FAU - Huijbers, Maartje G AU - Huijbers MG AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Vergoossen, Dana L AU - Vergoossen DL AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Fillie-Grijpma, Yvonne E AU - Fillie-Grijpma YE AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - van Es, Inge E AU - van Es IE AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Koning, Marvyn T AU - Koning MT AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Slot, Linda M AU - Slot LM AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Veelken, Hendrik AU - Veelken H AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Plomp, Jaap J AU - Plomp JJ AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - van der Maarel, Silvere M AU - van der Maarel SM AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. FAU - Verschuuren, Jan J AU - Verschuuren JJ AD - Department of Neurology (M.G.H., Y.E.F.-G., I.E.v.E., J.J.P., J.J.V.), Department of Human Genetics (M.G.H., D.L.V., Y.F.-G., I.E.v.E., S.M.v.d.M.), Department of Hematology (M.T.K., H.V.), and Department of Rheumatology (L.M.S.), Leiden University Medical Center, The Netherlands. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190221 PL - United States TA - Neurol Neuroimmunol Neuroinflamm JT - Neurology(R) neuroimmunology & neuroinflammation JID - 101636388 RN - 0 (Antibodies, Monoclonal) RN - 0 (Autoantibodies) RN - 0 (Receptors, Cholinergic) RN - 0 (Recombinant Proteins) RN - EC 2.7.10.1 (MUSK protein, human) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Adult MH - Antibodies, Monoclonal/*immunology/isolation & purification MH - Autoantibodies/*immunology/isolation & purification MH - Cells, Cultured MH - Humans MH - Muscle Fibers, Skeletal MH - Myasthenia Gravis/*immunology MH - Receptor Protein-Tyrosine Kinases/agonists/antagonists & inhibitors/*immunology MH - Receptors, Cholinergic/*immunology MH - Recombinant Proteins PMC - PMC6410930 EDAT- 2019/03/19 06:00 MHDA- 2019/03/19 06:01 PMCR- 2019/02/21 CRDT- 2019/03/19 06:00 PHST- 2018/12/03 00:00 [received] PHST- 2019/01/14 00:00 [accepted] PHST- 2019/03/19 06:00 [entrez] PHST- 2019/03/19 06:00 [pubmed] PHST- 2019/03/19 06:01 [medline] PHST- 2019/02/21 00:00 [pmc-release] AID - NEURIMMINFL2018019430 [pii] AID - 10.1212/NXI.0000000000000547 [doi] PST - epublish SO - Neurol Neuroimmunol Neuroinflamm. 2019 Feb 21;6(3):e547. doi: 10.1212/NXI.0000000000000547. eCollection 2019 May.